Nuvation Bio Inc.
NYSE · us_market
No AI insight generated yet for this ticker.
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment. The company's lead product candidate is IBTROZI (taletrectinib), a ROS1 inhibitor for the treatment of patients with ROS1+ non-small cell lung cancer. It is also developing Safusidenib, an inhibitor of mutant isocitrate dehydrogenase 1 in phase 3 clinical trials for the maintenance treatment of high-risk or high-grade IDH1-mutant astrocytoma with safusidenib against placebo. The company was founded in 2018 and is headquartered in New York, New York.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| FidelityFMR | fundamental | 51.99M | $223.04M | 0.01% | Added+1.1% | 2026-03-31 |
| StateStreet | passive | 6.78M | $29.11M | 0.00% | Added+15.8% | 2026-03-31 |
| TwoSigma | quant | 2.68M | $11.51M | 0.01% | Added+264.7% | 2026-03-31 |
| Wellington | fundamental | 672.1K | $2.88M | 0.00% | Trimmed-25.3% | 2026-03-31 |
| RenTech | quant | 559.2K | $2.40M | 0.00% | New | 2026-03-31 |
| DEShaw | quant | 393.0K | $1.69M | 0.00% | Trimmed-55.1% | 2026-03-31 |
| TRowePrice | fundamental | 303.6K | $1.30K | 0.00% | Trimmed-88.8% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-06upcoming | -0.12 | — | — |
| 2026-05-04 | 0.05 | 0.04 | -23.60% |
| 2026-03-02 | -0.04 | -0.09 | -91.11% |
| 2025-11-03 | -0.17 | -0.16 | +5.88% |
| 2025-08-07 | -0.17 | -0.17 | -0.85% |
| 2025-05-07 | -0.12 | -0.13 | -11.67% |
| 2025-03-06 | -0.12 | -0.12 | +2.92% |
| 2024-11-06 | -0.10 | -0.12 | -23.30% |
| 2024-08-05 | -0.05 | -1.85 | -3601.28% |
| 2024-05-14 | -0.05 | -0.04 | +11.00% |
| 2024-02-29 | -0.08 | -0.05 | +42.50% |
| 2023-11-02 | -0.08 | -0.06 | +18.88% |
| 2023-08-03 | -0.08 | -0.07 | +13.63% |
| 2023-05-04 | -0.06 | -0.08 | -28.67% |
| 2023-03-15 | -0.10 | -0.07 | +29.74% |
| 2022-11-03 | -0.15 | -0.11 | +24.25% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| NUVB | +6.46% | +9.63% | -46.65% | +125.47% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | +3.49% | +14.27% | -43.21% | +112.78% |